Poland· PL-100079889
Sulfarinol
A naphazoline product containing sulfathiazolum + naphazolini nitras, registered in Poland by TACTICA Pharmaceuticals Sp. z o. o.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Naphazoline is registered in 2 of 19 countries.
Countries holding a registration under ATC R01AB02 (naphazoline), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Naphazoline · ATC R01AB02
2 / 19 countries
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Sulfathiazolum + Naphazolini nitras
- Manufacturer
- TACTICA Pharmaceuticals Sp. z o. o.
- Country
- Poland (PL)
- ATC code
- R01AB02
- ATC class
- Naphazoline
- Defined daily dose
- 0.8 ml, N
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990332113
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
49 interactions on record for naphazoline.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Naphazoline · interactions on record
49 records
- 6 severe
- 43 moderate
Most severe, free to view
- MethylergometrineG02AB01severe
- DihydroergotamineN02CA01severe
- ErgotamineN02CA02severe
- MethysergideN02CA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under R01AB02
Naphazoline, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/358a208e-2ebf-471c-a4e7-9b149d975e3b GET /v1/drugs/358a208e-2ebf-471c-a4e7-9b149d975e3b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do nosa",
"source": "urpl",
"strength": "(50 mg + 1 mg)/ml",
"packaging": "05909990332113 ¦ OTC ¦ 12003\n1 butelka 20 ml",
"substance": "Sulfathiazolum 50 mg/ml + Naphazolini nitras 1 mg/ml",
"common_name": "Sulfathiazolum + Naphazolini nitras",
"pl_product_id": "100079889",
"pozwolenie_nr": "03321",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about naphazoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.